ArticleBMC oral health2025
Effect of scaling and root planing on TNF-α, IL-1β, and IL-10 levels in periodontitis patients with and without diabetes: a cross-sectional study.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of frailty index with incident complete tooth loss among middle-aged and older Chinese adults: a longitudinal cohort study based on CHARLS.BMC oral health · 2026Article
- Clinical and inflammatory changes following routine scaling and root planing in periodontitis patients with and without diabetes: a prospective observational cohort study.Frontiers in endocrinology · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo evaluate the effect of scaling and root planing (SRP) on clinical periodontal parameters and gingival crevicular fluid (GCF) levels of TNF-α, IL-1β, and IL-10 in periodontitis patients with and without diabetes.
methodsA cross-sectional study was conducted involving 76 patients diagnosed with periodontitis, including 38 with diabetes and 38 without diabetes. All participants received standardized SRP treatment. Periodontal clinical parameters and glycated hemoglobin (HbA1c) levels (in diabetic patients) were recorded at baseline and three months post-treatment. GCF samples were collected to assess concentrations of TNF-α, IL-1β, and IL-10 using ELISA. Changes in inflammatory cytokine levels were compared between the two groups before and after treatment.
resultsSRP led to significant improvements in probing depth (PD), clinical attachment loss (CAL), bleeding index (BI), and plaque index (PLI) in both groups, with no significant intergroup differences. Diabetic patients showed a mean HbA1c reduction of 0.30 ± 1.24%. TNF-α levels significantly decreased in both groups post-treatment (P < 0.001); however, post-treatment TNF-α levels remained significantly higher in the diabetes group than in the non-diabetes group (P < 0.001). No significant changes were observed in IL-1β levels in either group. IL-10 levels increased more in the non-diabetic group than in the diabetic group, though the difference was not statistically significant (P = 0.422).
conclusionSRP treatment effectively improves periodontal clinical outcomes and modulates local inflammatory mediator levels. These findings highlight the need for individualized treatment strategies and interdisciplinary management in diabetic patients with periodontitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.